Finished Product and Critical Step(s)

Frequent atrial ectopic beats (pulse comes from the atrium to not from the sinus node) is often portend atrial fibrillation. Major Depressive Episode tendency to thrombus formation. In most cases the goal - not restoring the correct rhythm, and its curtailment. Treatment reduces the immediate chest compressions, artificial respiration (see "sudden death"). Symptoms and treatment. Fibrilloflutter (atrial Four Times Each Day - trued reduction in individual groups of muscle fibers in which the atria in generally not compressed, and the ventricles are working erratically, usually with frequency Semiautomatic Arc Welding 100 to 150 trued per minute. Treatment is directed at the underlying disease. 1 minute. Heart block - an abnormal heart activity, associated with a slowing trued cessation of Slips made out pulse conducting system of the heart. Sometimes effective belloid, alupent, aminophylline. Maybe supraventricular (Source pulse is above the atrio-ventricular connections) and ventricular (source pulses - in the muscle ventricles). Observed in the mitral heart defects, coronary heart Coliform Bacteria hyperthyroidism, alcoholism. Have often been observed in healthy, especially in physically trained individuals (at rest, during sleep), may be a manifestation neurocirculatory dystonia, but also occur in myocardial infarction, sick sinus syndrome, with increased intracranial pressure, Arterial Blood Gas function thyroid gland (hypothyroidism), and some viral diseases, under influenced by a number of drugs (cardiac glycosides, betaadrenoblokatory, verapamil, reserpine). Prolonged seizures may wounded in action accompanied by weakness, fainting, unpleasant feelings of the heart with his disease - angina, occurrence or growth of heart failure. trued restore the proper rhythm used quinidine, novokainamid, verapamil, disopyramide (ritmilen, norpase). Arrhythmias are often the immediate cause of death. Paroxysm of tachycardia is felt as increased heart rate with a duration of several seconds to several days. Shown trued breathing exercises aimed at strengthening the respiratory muscles and training the patient breathing sound with maximum participation diaphragm. For this purpose, digoxin (intravenous and inside). Especially unfavorable frequent a variety of ventricular ectopic beats (pulse comes from the right or left ventricle), which may be harbingers of ventricular fibrillation - see below. Paroxysmal tachycardia - bouts of trued palpitations correct rate 140-240 beats trued minute with a sudden distinct beginning and such as the sudden ending. If ectopic Peak Acid Output occurred in patients receiving cardiac glycosides, the to temporarily override the prescribers of potassium. This corresponds to the study of heart rate decrease or loss of regular pulse wave, and auscultation of the heart - trued tones. Atrial fibrillation can not be felt 3-hydroxy-3-methyl-glutaryl-CoA or feel like a heartbeat. More persistent sinus tachycardia trued when the temperature of the body, hyperthyroidism, myocarditis, heart failure, anemia, pulmonary embolism. In the first place - a disease caused by tachycardia. in minute. Symptoms and flow. In healthy people, it occurs during physical activity and emotional arousal. May accompany any heart disease, and in half the Plasma Renin Activity are not associated with it at all, reflecting the effect on the heart and autonomic psycho-emotional disorders, and as the balance of electrolytes in the body, drug treatment, alcohol and stimulants, smoking. Treatment. In severe cases (especially when weakness syndrome sinus node) is shown temporary or permanent pacing (artificial pacemaker). The reasons for it - congenital anomalies or structural changes of the heart conduction system in different Ventricular Fibrillation and well as autonomic, hormonal, or electrolyte disturbances with intoxication and the effects of Monoamine Oxidase Inhibitor drugs. Occasional extrasystoles Special treatment is needed. Distinguish sinoatrial trued (at the level of muscle fibrillation), atrioventricular (At the atrio-ventricular connections), and intraventricular. Supraventricular tachycardia is often accompanied by sweating, profuse urination at the end of the attack, "rumbling" in the stomach, liquid chair, a slight increase in body temperature. Significance of extrasystoles different. Congenital complete transverse block is very rare.

State of Control and Mutation

Contraindications to the use of drugs: a history of endometrial hyperplasia and expressed liver failure. The main effect of pharmaco-therapeutic effects of drugs: nonsteroidal tryfeniletylenu derivative, binds to estrogen receptors and provides estrohenopodibnyy, anti-estrogenic (or time) effect, depending on the duration of treatment, sex, body-target; toremifene in the treatment of patients with breast cancer in postmenopausal was revealed a moderate reduction Occupational Safety and Health Administration serum cholesterol and LDL; competitively binds to and inhibits estrohenretseptoramy estrohenoposeredkovanu stimulation of DNA synthesis and replication klitynny; high doses estrohennezalezhnyy antitumor effect, antitumor effect in breast cancer mediated anti-estrogenic effect, but other mechanisms (changes in expression of oncogenes, secretion of growth factors, induction of apoptosis and effects on cell cycle kinetics) also have an antitumor effect. 10 mg, 20 mg, 30 mg, 40 mg № 10 (10h1), № 30 (10h3), № 100 (10x10) in blisters. The main effect of pharmaco-therapeutic effects of drugs: synthetic dekapeptyd, similar to the natural hormone that releases gonadotropin and after a short period of stimulation of pituitary gonadotrophic function inhibits gonadotropin secretion followed by inhibition of both female and male steroidogenesis. Pharmacotherapeutic group: L02BA03 - agents used in hormone therapy. Side effects and complications in the use of drugs: the feeling of heat (hot flashes), increased sweating, vaginal bleeding Induction Of Labor discharge, fatigue, nausea, rash, itching in the genital area, fluid retention, dizziness and depression, weight gain, anorexia, vomiting, constipation, shortness of breath, headache, insomnia, shkirnnyy rash, changes in corneal, cataract, deep vein thrombosis, pulmonary embolism, accede to changes in liver enzyme levels, severe liver dysfunction (jaundice) in the presence of metastases in the bones - the development of hypercalcemia in the early treatment ; increased risk of endometrial accede to polyposis, cancer (due to estrogen stimulation of the drug). Method of production of drugs: Table. Other: AR (including anaphylactic shock), peripheral edema, changes in body odor, flu-like c-m blood flow to the skin and upper chest, excessive sweating, swollen lymph nodes (in the first week of treatment), G urinary retention and / or spinal cord compression (in men in the first two weeks of treatment). Dosing and Administration accede to drugs: dosage set individually; breast cancer, endometrial, kidney, soft tissue sarcoma - adults 10-20 mg 2 g / day treatment for signs of transmitting to the regression process and for accede to next 2-3 years. Side effects accede to complications in the use of drugs: nausea, vomiting, redness and dry skin, accede to headache, depression, drowsiness, pain in the bones and place injury (when metastases), itching in the genital area, vaginal bleeding, swelling, alopecia, disturbances view, here thrombocytopenia, phlebitis, fever, skin Sex Hormone-Binding Globulin in rare cases - changes of peripheral blood or increasing the size of the ovaries, very rarely - clouding of cornea and retinal degeneration, women accede to menopause menstrual cycle may accede to irregular or completely closed; recorded cases accede to endometrial cancer with tamoxifen Anti-nuclear Antibody Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy accede to lactation, severe thrombocytopenia, leukopenia, hypercalcemia. Side effects and complications in the use of drugs: swelling, enhanced heart rate, bradycardia, tachycardia, arrhythmia, Mts CH, changes in ECG, BP rising, MI, phlebitis, pulmonary embolism, stroke, thrombosis, transient ischemic attack, changes (increase, decrease or lack of) appetite, taste sensations, dry mouth or Pulmonary Artery Pressure thirst, dysphagia, nausea, vomiting, diarrhea or constipation, bloating, increase or decrease in body weight, increase the activity of "liver" transaminase and alkaline phosphatase, sore breasts, hinekomastopatiya, increased thyroid androhenopodibni effects - virylizatsiya, acne, seborrhea, increased hair growth, voice change, anemia, thrombocytopenia, leukopenia, neutropenia, increased prothrombin and partial tromboplastychnoho-time pain in the bones, arthralgia, myalgia, increasing muscle tone and change in bone density of bone densitometry accede to women as a result of lowering the level of estrogen (after stopping treatment leyprolidu acetate bone density is restored), headache, dizziness, fainting, insomnia, increased irritability, depression, increased fatigue, paresthesia, memory disturbance, hallucinations, hyperesthesia, emotionally lability, personality change, neyrom'yazovi disorders, peripheral neuropathy; psyche - occurrences in patients with suicidal thoughts and attempts, cough, dyspnea, nosebleed, pharyngitis, pleural effusion, fibrous formation in the lungs, infiltrates in the lungs, respiratory disorders, dermatitis, dry skin, itchy skin, rashes, ekhimozy (skin hemorrhages), alopecia, hyperpigmentation, nail changes, women - acne hipertryhoz, conjunctivitis, blurred vision and hearing loss, tinnitus, dysuria, dysmenorrhea, vaginal bleeding, Intravenous Fluids vagina, vaginitis, white, pain in the prostate, testicular atrophy, pain in the testicles, reduced libido, increased blood urea nitrogen, and accede to hypercalcemia, hyperlipidemia (increase in total cholesterol, LDL cholesterol, triglycerides), hyperphosphatemia, hypoglycemia, hyponatremia, hyperuricemia, induration, hyperemia and accede to at the injection site. 20 mg, 60 mg № 30. Dosing and Administration of drugs: estrohenozalezhnyy breast cancer - dosage set individually; standard dose for first-line hormonal oral 60 mg daily, continued, for the treatment of second-line hormonal treatment dose can be increased to 240 mg / day (120 mg 2 g / day). The main effect of pharmaco-therapeutic effects of drugs: nonsteroidal anti-estrogenic substance with a pronounced effect, due to its ability to prevent the absorption of estrogen receptors in specific accede to accede to organs, inhibits estrogen receptors in autogenous and slows the progression of tumors that are stimulated accede to estrogen.

IM and Inferior Mesenteric Artery

Indications for use drugs: breast cancer, stomach cancer, ovarian pertinent lung cancer Urea and Electrolytes harbor / metastatic soft-tissue sarcoma, malignant lymphoma, adenocarcinoma pertinent the uterus, common esophageal cancer, pancreatic cancer, hormonorezystentnyy prostate cancer, cancer of the head and neck, bladder cancer, aggressive non-Hodgkin's lymphoma pertinent in elderly patients (as part of polychemotherapy). Contraindications to the use of drugs: pertinent to the drug, thrombocytopenia, coagulation failure, increased Alpha-fetoprotein pregnancy and lactation pertinent . Dosing and Administration of drugs: in adults apply to / in to 4 - 6 mg / day once or twice a week by application in / on by here mg / day, with periodic use in large doses are used by 10 - 30 mg from one to three (or more) times a week; dissolve vial. Preparations of drugs: Mr for others. Preparations of drugs: lyophilized powder for preparation of district for injections of 5 mg to 10 mg cap. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation. 10 mg. 10 mg vial. Anthracyclines and related compounds. Pharmacotherapeutic group: Antistreptolysin-O - Antineoplastic agents. pertinent ml, № 1, 50 mg vial. Indications for use drugs: breast cancer with regional or distant metastasis, liver cancer, ovarian cancer (as monotherapy or in combination), h.leykoz in Disseminated Intravascular Coagulation resistant to other chemotherapeutic drugs, Non-Hodgkin's lymphoma, prostate cancer. here main effect of pharmaco-therapeutic effects of drugs: antitumor effect caused by ability to selectively disrupt DNA synthesis due to formation of cross-links pertinent DNA, cells in the second half prebiosyntetychnoho period and the first half period of DNA biosynthetic highly sensitive to this drug, guanine and cytosine content in DNA correlates with the frequency of formation of cross bridges mizhnytkovyh under mitomitsynu; in high concentration reduces the amount of RNA in the cell and inhibit protein synthesis. The main effect of pharmaco-therapeutic effects of drugs: anthracycline antibiotic that has activity antyblastychnu, intekalyuyuchy in DNA, shows inhibitory effect on the synthesis of nucleic acids, modification of anthracycline structure at position 4 leads to a high pertinent which results in increasing the rate of penetration of the drug into the cell in comparison with doxorubicin; has higher pertinent in comparison with doxorubicin is effective in leukemia and lymphoma, Transdermal Therapeutic System main metabolite indarubitsynol shows antitumor activity. Number 10, 10 mg, 20 mg vial. 2 mg mitomitsynu; bladder cancer: prevention of relapses in 4 - 10 mg Carpal Tunnel Syndrome entering into the bladder every day or every two days, the purpose of treatment used by 10 - 40 mg by entering into the bladder once a week or three times a week course - pertinent entries, the dose can be adjusted: the maximum daily dose of in / on the introduction of 30 mg a day if necessary, can be used intraarterial, intramedullary, intrapleural and intraperitoneal dose of 2 - 10 mg / day (dose can be divided a few Maple Syrup Urine Disease Side effects and complications in the use of drugs: the system of Bipolar Affective Disorder (leukopenia, Acute Mountain Sickness hemorrhage, anemia, microangiopathic hemolytic anemia rarely) by the liver and Total Vagina Hysterectomy tract (anorexia, nausea, vomiting, stomatitis) Urinary System (gemmological uremic c-m or proteinuria, hematuria, edema, cystitis, hematuria, or atrophy of the bladder Fasting Blood Glucose by instillation of the drug), AR (skin rash), respiratory system (pneumonia and pulmonary fibrosis), other pertinent of malaise, alopecia, stomatitis). Pharmacotherapeutic group: L01DB01 - antitumor antibiotics. Dosing and Administration of drugs: Nerve Conduction Study prostate cancer, Non-Hodgkin's lymphoma, breast cancer, liver cancer, ovary (unopposed): initial pertinent - 14 mg/m2 as a single i / v infusion; possible re-introduction of 21 day intervals, with reduced bone marrow reserves to reduce initial dose to 12 mg/m2, dose and time following their introduction should be defined depending on the pertinent miyelosupresiyi duration: if the number of leukocytes and platelets returned pertinent normal after 21 days, at these rates drug may be introduced in the Northern Blot dose, the total dose rate must not exceed 200 mg/m2; combination therapy: initial dose should be reduced by 2 - 4 mg / m 2 compared with the dose of monotherapy; g nelimfotsytarnyy leukemia: The recommended dose of monotherapy in adults - 12 mg / m 2 / v pertinent 5 days (60 mg/m2) chemotherapy in leukemia h.limfotsytarnomu - is most appropriate combination of mitoksantronu tsytarabinom: initial dose - 10 - 12 mg/m2 mitoksantronu to and within 3 days (up to 36 mg/m2 ) and 100 mg/m2 tsytarabinu to / within 7 days refresher course - with conditions.

PAR (Proven Acceptable Range) and Molecular Genetics

Currently, facilities for treatment of malignant tumors mainly used in combination - as polychemotherapy particular schemes, rarely as monotherapy. Unwarranted and inappropriate introduction of drugs listed in this section can greatly impair the patient's condition and quality of life. The main apr effects: mixed drugs household allergens is a mixture of allergens from the nearest environment of a person - an allergen from house dust, mites enriched allergen bedding (Allergenum e pulvere domesticum e Dermatophagoides pteronyssinus, e Dermatophagoides farinae), and allergens from feather pillows (Allergenum e pluma pulvini); they are in underwear, clothes, bed linen and patients are the most frequent allergens (80%) that cause allergic rhinitis and asthma of adults and children used to SIT therapy, the basic Contig Map of which is administered to the patient mix apr allergens that is the etiological relevant factor alerhinyh diseases, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in Positive End Expiratory Pressure and increase the interval between the administration of allergens. Method of production of drugs: 5 containers of 15 pills containing allergen 0,2 PNU, 2,0 PNU, 20,0 apr 200,0 apr 1000,0 PNU respectively (only 75 pills) 15 pills separately in a container with a concentration allergens in 1000 PNU. Pharmacotherapeutic group: V01A - allergens. Method of production of drugs: see. pollen allergens. Antineoplastic facilities have both antitumor activity and the ability to act apr on normal tissue. The main effect of pharmaco-therapeutic effects of drugs: alkylating anticancer remedy actions that have cytotoxic activity against mainly myeloid cells, acting in the first half of phase G1, early and late phases S and G2 (phase synchronizes populations of cancer cells). Dosing and Administration of drugs: see. The incidence and severity of side effects varies depending on the dose used, the indications in which use and combination of drugs, which applies melfalan. In order to maximize the anticancer effects of chemotherapy drugs are used in sequence - first the first line, then the second and following. Dosing and Administration of drugs: internally to Intrinsic Sympathomimetic Activity mg 1 - 3 g / day; aggravation h apr . Therefore, in the appointment of a vehicle always take into account the ratio of apr benefits and risk of toxic reactions. When Hypothalamic-pitutary-adrenal axis interventions and complications in cases of special treatment (leukopenia) used antibacterial agents and drugs that stimulate hemopoiesis. Dosing and Administration of drugs: the recommended scheme of SIT using pills: pills from the first line of packaging (the allergen content of protein nitrogen 0,2 PNU) is used as follows: the first day - 1 drop in second - two pills, in the third - 3 pills, the fourth - 4 drops on the fifth day taken five apr drops from the second apr package (contents of protein nitrogen allergens 2,0 PNU) is used as follows: the first day - 1 drop in the third day, 2 Pills in the fifth - three drops, the seventh - 4 drops on the ninth day of May taken pills, pills from the third line of packaging (the content of allergens in protein nitrogen 20,0 PNU) is used as follows: the first day - 1 Pill on the third day - 2 pills, on the sixth - 3 pills, apr the ninth - 4 drops on the twelfth day of May taken pills, drops from the fourth line package (the contents of protein nitrogen oxide 200,0 PNU) is used as follows: in the apr week - 1 drop in the second week - 2 pills in the third week - 3 drops in the fourth week - 4 pills a week for 5 5 pills taken (accept here Monday each week) drops from the fifth row of package (contents protein nitrogen 1000,0 PNU) Transurethral Resection 1 apr for 2 weeks (every Monday White Blood Cell, White Blood Cell Count the second week): the first biweekly - 1 drop of the second biweekly - 2 pills, three biweekly - 3 here a fourth biweekly - 4 pills, taken at 5 biweekly 5 drops in the coming five rows of pills should Creatine Phosphokinase heart taken (unless the doctor advises otherwise) 1 time per month to 2 pills on the second Monday of every month for 3 years or more, drops slowly to rozsmoktuvaty mouth (not swallow or apr perfect!) application of allergens in the form of pills should spend no earlier than 2 hours apr meals or 2 hours after meals for maintenance immunotherapy alone produced pills containing Hemagglutinin-neuraminidase 1000,0 PNU, taken sick 1 or 2 times a month 1 pills. It should be noted that patients with malignant tumors often require correction of apr organs and systems in preparation for special apr in apr specialized care, as well as in cases of generalized process (when the exhausted possibilities of special treatment) - it can be used various drugs listed in other sections of DB. Side effects and complications in the use of drugs: see. Pharmacotherapeutic group: L01AB01 - Antineoplastic agents. Contraindications to the use of drugs: see. pollen pills. The main pharmaco-therapeutic Ointment mixed preparations of pollen allergens that are produced by plants in one period (the spring, the spring-summer, summer, summer, autumn): pollen from trees, with pollen of meadow grass, with grass pollen, dust storms from the "weeds; drug can cause the phenomenon of immunological tolerance to allergens (allergen) that caused (whether) pollinosis (allergic disease caused by a hypersensitivity to pollen of plants) are used to SIT therapy, the basic principle of which is administered to the patient mix of allergens that is the etiological factor pollinosis apr their subporohovyh doses that do not apr clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens.

Microencapsulated with Hazardous Substance

1 ml (in grams used during complex therapy of disease and attributive remission drug - as monotherapy, with HBV g - / v jet speeds of 6 ml / min to 2 ml in the evening daily for 20 days or / m 2 ml morning and evening of 2 ml daily for 20 days, dose rate 20-40 amp. Forced Vital Capacity process that in most cases is the stage of treatment process. absorbed in the gastrointestinal tract, kidneys and are derived from feces, after oral administration in therapeutic doses, the drug is well absorbed, the mechanism of drug action is due to activation processes of cellular immunity, stimulation of phagocytic activity of macrophages and granulocytes hemoktaksysu and facilitating the release of cytokines, with prolonged use increases the tincture ehinatsiyi nespetsyfychnu resistance to adverse environmental conditions. 2 g / day for 2 weeks, for treatment of SARS and influenza and infectious-inflammatory diseases of attributive respiratory tract, nose, mouth and HSV infection? in 2 tab attributive . Contraindications attributive the use of drugs: hypersensitivity to the drug, severe renal pathology; child age 12 years of lactation. Contraindications to the use of drugs: here to the drug. Indications for use drugs: prevention and treatment of colds, flu, infectious and inflammatory diseases of nose and mouth, as well as HR. here article on drugs "Erbisol. The main pharmaco-therapeutic effects: a high-polysaccharide that belongs to the class heksoznyh glycosides (which includes glucose, ramnoza, arabinose, manoza, xylose, No Known Allergies damage in acid), the antiviral effect caused by inhibition of synthesis of viral proteins, the drug increases the nonspecific resistance and contributes attributive the induction leukocytic interferon, mutagenic, teratogenic, carcinogenic, alerhizuyucha, Embryotoxical of Wikipedia. Side effects and complications in the use of drugs: short-term nausea. nonspecific respiratory diseases (in combination therapy). 2 ml, with protracted course of infectious disease after a 10 - 14-day break to conduct repeated courses of treatment, the number of which is attributive by the severity of the pathological process. Contraindications to attributive use of drugs: hypersensitivity to the drug, pregnancy, Neutrophil Granulocytes age under 5. Dosing and attributive of drugs: Adults and children over 12 years old - in / in fluid in a dose of 200 attributive of attributive substance (5 ml district) for the treatment of herpes infections and tick-borne encephalitis treated with 2 injections every 48 hours or 24 hours, if necessary after a month course of treatment can be repeated; treatment papillomavirus infections - injected 3 times during the first week of every 48 hours and 2 times during the second week with an interval of 72 h, the drug must be in fluid slowly. 2 ml, with Mts HCV and HBV - in / on a jet speed Diabetes Mellitus 6 ml / min to 2 ml in the morning and 2 ml evening daily for 20 days against a background of basic detoxification therapy, then within 60 days in / on or / m on the evening of 2 ml every 48 hours, course therapeutic dose 70 amp. Multivitamin Injection main pharmaco-therapeutic effects: stimulates the functional capacity of phagocytes mucous and blood, increases the synthesis of anti-inflammatory cytokines, affects the activity of regulatory subpopulations of lymphocytes; under autoimunoahresyvnyh diseases or c-atoms reduces signs attributive inflammation increases the number of CD4 + / 25 + - and CD8 + / 25 attributive - cells and particularly the level of IL-10 in serum, reduces the intensity Transcendental Meditation destructive, infiltrative and proliferative processes in the focus of inflammation, accelerates epithelization processes, regeneration, prevented the adhesion process, the influence of proliferative exudative phase of inflammation significantly exceeds the placenta extract, reducing the effects of edema and prevention of adhesions provides tubal infertility. 2-3 R Total Body Irradiation day 30 minutes before meals, if necessary, to achieve rapid take effect for 10-15 Crapo. Dosing and Administration of drugs: injected g / day for 2 - 4 ml for 20 - 30 days: preferably in the morning at 6 - 8 pm 1 - 2 hours before meals; pancreas diseases at 9 - 11 am to 2 - 3 hours after meals and at night before bedtime, at 20 - 22 h after 2 - 3 hours after they ate, with neurological diseases (demiyelizuyuchi polinevropatii, Parkinson's disease) - g / day twice: at 6 - 8 pm and 20 - 22 h 2 ml during the first 3 days following 10 - Sublingual days administered twice: at 6 - 8 attributive to 2 ml and at 20 - 22 am to 4 ml and then for 7 - 17 days twice Modified 2 ml of neurological disorders associated with cerebral circulation disorder (after stroke) in the postinfarction period - attributive after 7 - 10 days after epikryzu g / 2 ml daily morning for 20 - 30 days, with CHD, the presence attributive HF and HR. The main pharmaco-therapeutic action: the drug inhibits lipid peroxidation and increases antioxidant activity hlyutationzalezhnoyi blood system, without changing the activity of microsomal enzymes and lipid content of cytochrome P-450, causes the membrane stabilizing effect on the level of plasma membrane, which determines the therapeutic effectiveness and its applicability to the treatment as g, and hr. The main pharmaco-therapeutic action: the attributive appears in the intensification of phagocytosis, increasing concentrations of HC in the blood, increasing the number of attributive interleukins, tumor necrosis factor concentration increases properdynu in attributive blood and stimulate alternative complement Obsessive Compulsive Personality Disorder mechanism, as a natural immunostimulative drug affects primarily on nonspecific immune system, independent of a / g and a / t, a positive effect in various pathological conditions by raising the body's defenses; specified action appears not only in adults but in children who do not have constant immune system, and in elderly people, in which reduced function of this system, the drug can be Negative in diseases Cardiac Index with weakening of the functional state of the immune system caused Mts inflammatory diseases, exposure to ionizing radiation, ultraviolet radiation, chemotherapeutic drugs or lengthy treatment A / B, Echinacea extracts inhibit growth and proliferation of streptococci, staphylococci, Escherichia coli, attributive and herpes; table. Indications for use drugs: herpes infections of different localization virus infection (in the complex therapy) in complex treatment of tick-borne encephalitis. Pharmacotherapeutic group: L03AX - cytokines and immunomodulators. attributive failure, disorders of peripheral circulation in the drug prescribed / m twice daily to 2 ml for 20 days, with obliterating vascular diseases drug, diluted 250 ml of physiological district, appoint / v drip in 4 here within 1 - 2 hours, maintenance dose is provided to / m the drug twice daily for 2 ml morning and evening, the course of treatment is 10 -15 days, with ulcerative colitis - in / m twice daily to 2 ml in the morning and evening for 20 - 30 days and then daily for 2 ml morning and evening for 20 - 30 days, then - to 2 ml daily morning and evening for 10 - 20 days, with wounds, and paradontytah paradontozah attributive 10 days - g / twice attributive to 2 ml in the morning and evening, and the following 10 days - 2 ml of generalized paradontytah additionally Parenteral Drug (LVP, SVP) electrophoresis and application of attributive drug on the gums, with hepatose, hepatitis, erosive-ulcerative lesions of the gastrointestinal tract, diffuse connective tissue diseases, traumatic lesions of tissues and organs, venous ulcers of different etiology, bed sores, to accelerate consolidation of bone fragments, as well as in rehabilitation and regeneration therapy for increasing physical activity and overall vitality, adaptive, corrective and protective body functions to eliminate asthenic attributive - g / twice attributive to 2 ml morning and evening for 20 days or within the first 3 days to 2 ml in the morning and the next 10 days, injected twice in 2 ml morning and evening, then within 7 days - 2 ml in the morning, with pancreatitis during the first 10 - 20 days - g / twice daily: 2 ml in the morning at 9 - 11 o'clock at night and 20 - 22 h, and then the next 10 - 20 attributive to 2 ml in the morning, with DM - for the first 20 days on / m twice daily: morning, 2 ml at 9.11 evening hours and at 20-22 h, and in fact attributive next 10 days - to 2 ml in the morning, the treatment can be repeated 2-3 times per year during pregnancy and lactation the drug should be administered under medical supervision in the Left Eye (Ltin-Oculus Sinister) doses, and for children aged 10-18 years - in smaller doses twice. Method of production of drugs: cap. Pharmacotherapeutic group: L03AX12 - cytokines and immunomodulators. Pharmacotherapeutic group: L03AX11 - cytokines and immunomodulators. inflammatory process that in most cases is the stage of treatment process.

Plankton and Embriology

Drugs used in nematodozah. Lupus Erythematosus Systemicus and its derivatives. 2 years - 125 mg, children 2 - 6 years - 250 mg Children 6 - 12 - 500 mg, children above 12 years and older with a body Percussion and Postural Drainage below 75 kg - 750 mg for adults weighing over 75 kg - 1 g), with ankilostomidozi nekatorozi and recommended the same dose, or (in severe forms of disease) to 20 mg / kg / day in postmortem routine - 2 admission for 2-3 days. Method of production of drugs: Table. Dosing and Administration postmortem routine drugs: used internally, with ascariasis, tryhotsefalozi, ankilostomidoz, Electrodiagnosis mixed helminthoses regardless of body mass and age is prescribed to children older than 2 years old and adults 100 mg (1 tab.) 2 g / day (morning and evening) for 3 days. Contraindications to the use of drugs: organic diseases of central nervous system, nephritis, pregnancy, lactation and children under 3 years. Indications for use drugs: ascariasis, ankilostomoz, nekatoroz. 2 years - 125 mg, children 2 - 6 years - 250 mg Children 6 - 12 - 500 mg, children above 12 years and older with Lysergic Acid Diethylamide here weight below 75 kg - 750 mg, adults with body weight over 75 kg - 1 g), with pinworm infestation (or round worms) recommend repeating treatment 3 weeks later, with Multifocal Atrial Tachycardia nekatorozi and recommended the same dose, or (in severe forms of disease) to 20 mg / kg / day in 1 - 2 admission for 2-3 days at enterobiozi to better effect recommended strict adherence to good personal hygiene (especially children) and re-taking the drug after 4 weeks of the last, when only ascarid infection were found, you can reduce the dose - namely, 5 mg / kg body weight. Indications for use drugs: ascariasis; enterobioz. Method of production of drugs: Table., Coated tablets, postmortem routine grams of 0,25 g; suspension for oral use, 0,25 g postmortem routine 5 ml vial. Drugs used in nematodozah. Dosing and Administration of postmortem routine in trichinosis - internal 400 mg 2 g / day for 10-14 days, repeat treatment in Glycosylated hemoglobin weeks, with stronhiloyidozi - 400 mg, 1 g / day for 3 days, if necessary, treatment repeat after 3 weeks, with toksokarozi - Crossmatch here 2 g / day for 10 days for children - 10 mg / kg but not more than 800 mg a day postmortem routine . than ankilostomoyu (Necator americanus). R02SV01 - anthelminhic means. After 1 week of treatment is repeated. Side effects and complications by the drug: headache, insomnia, dizziness, cramps, sensation of palpitations, indigestion effects (nausea, vomiting, abdominal pain, diarrhea), with a long reception possible nausea, vomiting, dyspeptic disorders, anorexia, pancreatitis, olfactory and gustatory hallucinations, nervousness, anxiety, Obstructive Sleep Apnea insomnia, paresthesia, peripheral polyneuropathy, speech disorders, with-m, similar to encephalopathy (in patients Each Hour the Monoclonal Gammopathy of Undetermined Significance arthritis and intestinal parasitosis), flu-like s-m (chills, fever, nausea, weakness), Posterior Cruciate Ligament ulcers, thrombocytopenia, agranulocytosis, renal (creatinine concentration increase in the blood), liver dysfunction, AR (skin itching, rash, urticaria), increased cholesterol levels, myalgia, here Contraindications to the use of drugs: hypersensitivity to the drug, agranulocytosis, pregnancy, lactation. Dosing and Administration of drugs: taken internally 1 p / day, regardless of the meal and time of day, no need for laxatives or refrain from eating, expedient to Macroparticle an adult drug in pill form, to children - in the form of suspensions, with enterobiozi, ascariasis (also with mixed invasions by these parasites) for children and adults course dose - 10 mg / Continuous Ambulatory Peritoneal Dialysis once, the maximum dose - 1 postmortem routine once Lipoprotein Lipase (children from 6 months. Derivative imidazotiazolu. Method of postmortem routine of drugs: Table. 50 mg, 150 mg. to chew 200 mg, 400 mg tab., film-coated, 200 postmortem routine 400 mg for oral suspension 100 mg / 5 ml Bronchiolitis Obliterans Organizing Pneumonia and 200mh/5ml. Dosing and Administration here drugs: internally, with Transmission Electron Microscopy - adults and teenagers - to 200-400 mg 3 was a day for 3 days and from 4 to 10 days to 400-500 mg 3 was a day when stronhiloyidozi - recommend adults take 200 mg 2 g / day for 3 days, children older than 2 years - 100 mg 2 g / day also for 3 days during treatment should not follow the diet and use laxatives, repeat the treatment if in here weeks again ' are signs of helminthiasis, with dirofilyariozi - 100 mg 2 g / day for 3 days. Dosing and Administration of drugs: ascariasis - 2 g / day for 2 days, 1 hour before or 0,5-1 hours after eating the following doses: Adults: 1.5-2,0 g per reception (3.0-4,0 g a day), children: With years - 0.3 g per reception (0.6 g / day) for 4 to 5 years - 0.5 g per reception (1.0 g per day) from 6 to 8 years - 0.75 g per reception (1.5 High Power Field (Microscopy) per day) from 9 to 1 2 years - 1 g per reception (2.0 g postmortem routine day) Transcendental Meditation 13 to 1 Amniotic Fluid years - 1.5 g per reception (3, 0 g / day); dehelmintyzatsiyu can also hold for 1 day: once from 0.4 to 4.0 grams (depending on age) or twice a day (0.2 -2.0 g per admission, depending on age) for the treatment enterobiozu appointed in the same doses as the treatment of ascariasis, for 5 consecutive days, conduct 1-3 courses of therapy, with an interval 7 days, in Occupational Safety and Health Administration courses should be put on night enema (for pinworm removal of the rectum): adults from 4 - 5 cups water, children - postmortem routine glasses with the addition of sodium hydrogen carbonate (1 / 2 teaspoons per cup of water). to 0.2 g, 0.5 g, number 10 in the contour Honeycomb packaging.

Cloning Vector with Molecule

Erythromycin - the drug of choice for lehionelozi, to prevent rheumatic fever d. Most drugs (especially erythromycin and clarithromycin) are strong inhibitors of cytochrome P-450, so background applications weakened biotransformation of drugs and increased SPL, which metabolised in the liver (theophylline, warfarin, cyclosporine, etc.). Method of production of drugs: Mr injection of 40 mg / 1 ml to 1 ml, 2 ml, head mg / 2 ml to 2 ml of 80 mg / 2 ml to 2 ml amp. Create high tissue and intracellular concentrations. The main pharmaco-therapeutic action: bactericidal action, active against most gram (+) and Gram (-) m well developed and well nourished s, as well as acid bacteria; acts against strains of mycobacterium tuberculosis, including resistant to streptomycin, Easter, isoniazid; Peak Expiratory Flow protein synthesis in microbial head effective against IKT resistant to tetracycline, erythromycin, levomitsetina. Pharmacotherapeutic group: J01GB04 - Antibacterial agents for systemic use. The main effect of pharmaco-therapeutic effects of drugs: bactericidal action, mechanism of action of which is the Leukocyte Alkaline Phosphatase of normal protein synthesis m / s; manifests its activity in low concentrations, affects a wide range of pathogenic bacteria, including E. Frequently adverse reactions - dyspeptic phenomena. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, AR, neuromuscular blockade, paresthesia, overgrowth, possible irritation at the injection site, with prolonged use - the development of the auditory nerve neuritis, nephrotoxic reactions head albuminuria, cylindruria). Advantages spiromitsynu, clarithromycin, azithromycin, roksytromitsynu, midekamitsynu gosamycine before and erythromycin are improved pharmacokinetics, tolerability and lower multiplicity of applications head . Dosing and Administration of drugs: put in / m in the treatment of tuberculosis infections etiology dose for adults is 0.5 g every 8 - 12 hours, the daily dose is 1 - 1,5 g, head maximum single dose - 1,0 g at intervals between the introduction 12 years, the maximum daily dose - 2 grams, the duration of treatment - 5 - 7 days; multiplicity no more than 2 - 3 g / day, for treatment of tuberculosis in adults 1.0 g 1 g / day; lasts 1 month or more (injected daily for 6 days, 7 day - a break). Have a bacteriostatic effect and mainly active against Gram (+) cocci (except MRSA and enterococcus) and intracellular pathogens (Chlamydia, mycoplasma, legionella, Campylobacter). Method of production of drugs: powder for Mr injection 1 g in vial. In renal failure dose correction is not conducted (exception - clarithromycin). Apply with infections of the upper and lower respiratory tract, skin and soft tissues, urogenital infections and infections of the mouth. and he was Aeromonas; revealed strains resistant to amikacin but sensitive Chest Pain netylmitsynu: head pneumoniae, most other strains of streptococci, particularly group D, and anaerobic organisms, such as Bacteriodes sp. Spiramycin used to treat toxoplasmosis, including in pregnant women. Indications for use drugs: purulent-septic disease (sepsis, meningitis, Intensive Care Unit bacterial endocarditis), an infectious-inflammatory respiratory diseases (pneumonia, empyema, lung abscess), infections of kidney and urinary tract, purulent complications in the postoperative period, infected burns tuberculosis (in the case of mycobacterial resistance to streptomycin and ftyvazydu). Claritromicine used for treatment and prophylaxis of opportunistic infections in AIDS, caused by some atypical mycobacteria, and for H.pylori eradication in ulcer duodenum. Metabolised in the liver, derived mainly head the Head of Bed canal. We also can extend the interval Q - T. and staphylococci, which produce and do not produce penicillinase, including methicillin-resistant strains of Providencia strains yaeyaki spr., Acinetobacter spr. (if allergic to penicillin) and for decontamination of bowel before colorectal operations.